US Patent Issued to Peptron on Sept. 15 for "Sustained release formulation composition comprising semaglutide or pharmaceutically acceptable salt thereof" (South Korean Inventors)

ALEXANDRIA, Va., Sept. 15 -- United States Patent no. 12,734,219, issued on Sept. 15, was assigned to Peptron inc. (Daejeon, South Korea).

"Sustained release formulation composition comprising semaglutide or pharmaceutically acceptable salt thereof" was invented by Seung Gu Chang (Daejeon, South Korea), Jae Pyoung Cho (Chungcheongbuk-do, South Korea), Ji Hyang Lee (Chungcheongbuk-do, South Korea), Eun Seo Jang (Daejeon, South Korea) and Ho Il Choi (Daejeon, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to sustained-release microspheres which include semaglutide or a pharmaceutically acceptable salt thereof, and a sustained-release formulation composition including t...